Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
|
22.01.2026 13:48:20
|
Abbott Laboratories Announces Decline In Q4 Bottom Line
(RTTNews) - Abbott Laboratories (ABT) reported a profit for fourth quarter that Drops, from last year
The company's earnings totaled $1.776 billion, or $1.01 per share. This compares with $9.229 billion, or $5.27 per share, last year.
Excluding items, Abbott Laboratories reported adjusted earnings of $2.63 billion or $1.50 per share for the period.
The company's revenue for the period rose 4.4% to $11.459 billion from $10.974 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings: $1.776 Bln. vs. $9.229 Bln. last year. -EPS: $1.01 vs. $5.27 last year. -Revenue: $11.459 Bln vs. $10.974 Bln last year.
-Guidance: Next quarter EPS guidance: $ 1.12 To $ 1.18
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratories
Analysen zu Abbott Laboratories
Aktien in diesem Artikel
| Abbott Laboratories | 90,20 | -1,23% |
|